Propensity score analysis of oesophageal cancer treatment with surgery or definitive chemoradiotherapy

British Journal of Surgery

Volumn 101, Issue 5, 2014, Pages 502-510

  Karran, A ^a   Blake, P ^a   Chan, D ^a   Reid, T D ^a   Davies, I L ^a   Kelly, M ^b   Roberts, S A ^a   Crosby, T ^c   Lewis, W G ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c VELINDRE CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CHEMORADIOTHERAPY; COMPARATIVE STUDY; EPIDEMIOLOGY; ESOPHAGUS RESECTION; ESOPHAGUS TUMOR; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE; UNITED KINGDOM; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896123350     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9437     Document Type: Article

References (39)

1. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer; a randomised controlled trial. Lancet 2002; 359: 1727-1733.
2. Royal College of Surgeons of England. National Oesophago-Gastric Cancer Audit 2013. http://www.hscic.gov.uk/catalogue/PUB11093/clin-audi-supp-prog-oeso- gast-2013-rep.pdf [accessed 9 December 2013].
3. Al-Sarira AA, David G, Willmott S, Slavin JP, Deakin M, Corless DJ,. Oesophagectomy practice and outcomes in England. Br J Surg 2007; 94: 585-591.
4. Allum WH, Stenning SP, Bancewicz J, Clark PI, Langley RE,. Long-term results of a randomised trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol 2009; 27: 5062-5067.
5. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BPL, et al.; CROSS group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
6. Reid TD, Davies LI, Mason J, Roberts SA, Crosby TDL, Lewis WG,. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma. Clin Oncol 2012; 24: 617-624.
7. Morgan MA, Lewis WG, Casbard A, Roberts SA, Adams R, Clark GWB, et al. Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinoma. Br J Surg 2009; 96: 1300-1307.
8. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623-1627.
9. Crosby TDL, Brewster AE, Borley A, Perschky L, Kehagioglou P, Court J, et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer 2004; 90: 70-75.
10. Gwynne S, Hurt C, Evans M, Holden C, Vout L, Crosby T,. Definitive chemoradiation for oesophageal cancer-a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol 2011; 2: 182-188.
11. Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007; 25: 1160-1168.
12. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-2317.
13. Chan A, Wong W,. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized oesophageal carcinoma. Int J Radiat Oncol Biol Phys 1999; 45: 265-270.
14. Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J, et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol 2000; 18: 455-462.
15. Kaneko K, Ito H, Konishi K, Kurahashi T, Ito T, Katagiri A,. Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous carcinoma of the oesophagus. Br J Cancer 2003; 88: 18-24.
16. Geh JI,. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2001; 38: 300-313.
17. Chiu PW, Chan AC, Leung SF, Leong HT, Li MK, Au-Yeung AC, et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005; 9: 794-802.
18. Strong S, Brookes S, Donovan J, Hollingworth W, Crosby T, Griffin M, et al. The feasibility of conducting a randomised trial of surgical and non-surgical treatment for oesophageal squamous cell cancer: definitive chemoradiotherapy versus chemotherapy and surgery. Br J Surg 2011; 98 (Suppl 7): 21.
19. Rosenbaum PR, Rubin DB,. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55.
20. D'Agostino RB Jr., Propensity score methods for bias reduction in the comparison of a treatment to a non-randomised control group. Stat Med 1998; 17: 2265-2281.
21. Austin PC,. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011; 46: 399-424.
22. Adamina M, Guller U, Weber WP, Oertli D,. Propensity scores and the surgeon. Br J Surg 2006; 93: 389-394.
23. Guller U, Anstrom KJ, Holman WL, Allman RM, Sansom M, Peterson ED,. Outcomes of early extubation after bypass surgery in the elderly. Ann Thorac Surg 2004; 77: 781-788.
24. Myers WO, Gersh BJ, Fisher LD, Mock MB, Holmes DR, Schaff HV, et al. Time to first new myocardial infarction in patients with mild angina and three-vessel disease comparing medicine and early surgery: a CASS Registry study of survival. Coronary Artery Surgery Study. Ann Thorac Surg 1987; 43: 599-612.
25. Sobin LH, Wittekind C, (eds). UICC TNM Classification of Malignant Tumours (6th edn). Wiley: New York, 2002.
26. Mukherjee S, Abraham J, Brewster A, Hardwick R, Havard T, Lewis W, et al. Pilot study of preoperative combined modality treatment for locally advanced operable oesophageal carcinoma: toxicities and long term outcome. Clin Oncol (R Coll Radiol) 2006; 18: 338-344.
27. Lewis I., The surgical treatment of carcinoma of the oesophagus; with special reference to new operation for growths of middle third. Br J Surg 1946; 34: 18-31.
28. Tanner IC,. The present position of carcinoma of the oesophagus. Postgrad Med J 1947; 23: 109-139.
29. Orringer MB,. Transhiatal esophagectomy for benign disease. J Thorac Cardiovasc Surg 1985; 90: 649-655.
30. US Department of Health and Human Services; National Institutes of Health; National Cancer Institute. Common Terminology Criteria for Adverse Events, version 4·0, 2009. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03- 2010-06-14-QuickReference-5x7.pdf [accessed 20 January 2014].
31. Kelson DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-1984.
32. Carstens H, Albertsson M, Friesland S, Adell G, Frykholm G, Wagenius HE, et al. A randomized trial of chemoradiotherapy versus surgery alone in patients with resectable esophageal cancer. Proc Am Soc Clin Oncol 2007; 25 (Suppl): 4530.
33. Nicholas J, Gulliford MC,. Commentary: What is a propensity score? Br J Gen Pract 2008; 58: 687.
34. Cook EF, Goldman L,. Performance of tests of significance on stratification by a multivariate confounder or by a propensity score. J Clin Epidemiol 1989; 42: 317-324.
35. Adams R, Morgan M, Mukherjee S, Brewster A, Maughan T, Morrey D, et al. A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. Eur J Surg Oncol 2007; 33: 307-313.
36. Morgan MA, Lewis WG, Crosby TDL, Escofet X, Roberts SA, Brewster AE, et al. Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy for patients diagnosed with oesophageal cancer. Br J Surg 2007; 94: 1509-1514.
37. Kelson DP, Winter KA, Gunderson LL, Mortimer J, Estes NC, Haller DG, et al.; Radiation Therapy Oncology Group; USA Intergroup. Long-term results of RTOG Trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery alone for esophageal cancer. J Clin Oncol 2007; 25: 3719-3725.
38. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006; 354: 567-578.
39. Crosby TDL, Evans M,. The management of locally advanced carcinoma of the oesophagus-SCOPE for improvement? Clin Oncol (R Coll Radiol) 2009; 21: 281-284.